In most cases, ECMO implantation was performed on the site of collapse in patients who developed in-hospital refractory cardiac arrest, and in the catheterization laboratory in patients who developed out-of-hospital refractory arrest or in the case of severe cardiogenic shock. The interventional cardiologist implanted the cannulae while the two nurses assembled and primed the circuit with normal heparinated saline. The femoral artery was cannulated according to the Seldinger technique with a 14-17 Fr cannula (depending on the size of the patient) and the femoral vein with a 21 Fr cannula.
Puncture was echoassisted when required, especially in the case of refractory cardiac arrest due to the absence of a femoral arterial pulse. In some cases, distal femoral arterial perfusion was performed using a 5 Fr sheath, with an echoguided antegrade puncture to avoid ischaemia of the distal limb when required (Figure 1 ).
The patient population was divided into two groups according to the patient's condition at the time of implantation: patients implanted in refractory cardiac arrest (during cardiac massage) and patients implanted in severe cardiogenic shock. (Figure 2) . Twenty-four patients had refractory cardiac arrest and 27 were in refractory cardiogenic shock ( Figure 3 ).
As shown in Table 3 , ECMO implantation was successful in 44/51 patients (86%). The success rate was higher in patients with cardiogenic shock than in those with refractory cardiac arrest (96% vs 75%; P=0.042). Of the seven implantation failures, six were due to catheterization failure and one to centrifugal pump failure (breakdown) ( Table 3) . In-hospital complications occurred in 43 of the 51 patients (Table 3) . Sixteen patients experienced one complication and 27 patients experienced two or more. The most frequent complication was major bleeding. Overall, 14/51 patients (27%) were discharged alive and in a good neurological condition: 13/27 (48%) patients who were in cardiogenic shock and 1/24 (4%) in refractory cardiac arrest ( Figure 5 ). All 14 patients discharged alive were still alive after a media of 17 (IQR 13-26) months. One patient underwent heart transplantation.
Background
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Our experience suggests that ECMO implantation performed by an experienced interventional cardiology team, in a hospital without on-site cardiac surgery facilities, is a feasible treatment approach. Of the 37 deaths that occurred in hospital, seven occurred during ECMO implantation. Of the remaining 30 deaths, 23 occurred during the first 24 hours (Figure 6 ). Twenty-seven patients died under ECMO and three after weaning off the device and before discharge from hospital ( Table 3 ).The neurological condition of all of the surviving patients was good. 
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As shown in Figure 4 ,13/24 patients with refractory cardiac arrest and 6/17 with out-of-hospital refractory cardiac arrest fulfilled the predefined inclusion time criteria of no flow ≤ 5 minutes and low flow ≤ 100 minutes. 
